Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Iulian
Iulian holds a PhD in Computer Science from Harvard University. He graduated with a BA and MA in Computer Science from the Polytechnic University of Catalonia in Barcelona, Spain.
Eliza
Eliza majored in English and won several awards for her academic work at Bard College. She is now a PhD candidate in English at Harvard, where she studies nineteenth-century literature and the history of the novel.